Skip to main content
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: Neuropharmacology. 2018 Mar 1;142:240–250. doi: 10.1016/j.neuropharm.2018.02.033

Table 1.

Effects of DOI, 25C-NBOMe, 25I-NBOMe, 2C-C and 2C-I on 5-HT2A receptor binding, calcium mobilization mediated by 5-HT2A and 5-HT2C receptors, and behaviors.

Compound 5-HT2A
Inhibition
of Binding
IC50
(nM)
5-HT2A
Mobilization
of Calcium++
EC50
(nM)
[%Emax]
5-HT2C
Mobilization
of Calcium++
EC50
(nM)
[% Emax]
Rat
WDS
ED50
(mg/kg, sc)
Rat
BMC
ED50
(mg/kg, sc)
DOI 56.1 ± 4.9 1.83 ± 0.3 [109] 47.7 ± 3.0 [50] 0.065 ± 0.024 0.180 ± 0.066
25C-NBOMe 8.7 ± 1.0 61.7 ± 3.5 [104] 178 ± 25 [60] 0.010 ± 0.005 0.021 ± 0.008
25I-NBOMe 3.9 ± 0.4 34.7 ± 4.2 [108] 88.9 ± 11 [70] 0.062 ± 0.026 0.037 ± 0.011
2C-C 307.5 ± 21.6 4.57 ± 0.5 [95] 77.6 ± 5.5 [29] 0.173 ± 0.066 0.550 ± 0.190
2C-I 124.9 ± 13.0 3.97 ± 0.7 [89] 47.2 ± 6.7 [28] 0.690 ± 0.268 0.192 ± 0.060
HHS Vulnerability Disclosure